NMN: Labeling Standards and Cross-Border Compliance

Abstract

Beta-Nicotinamide Mononucleotide (NMN) has attracted sustained market attention in Japan, China, the United States, Europe, and other regions as a dietary supplement ingredient. As the global market has expanded, so too have concerns about labeling disputes and cross-border compliance risks associated with this ingredient. This paper examines three core dimensions — ingredient content labeling requirements, product label regulatory obligations, and cross-border purchase compliance — to map out the essential compliance logic under Japan's current regulatory framework, providing consumers, procurement professionals, and industry practitioners with actionable reference guidance. This paper addresses only verifiable regulatory facts and standards; it does not make any claims regarding health efficacy or medical outcomes.

---

1. Overview of Japan's Regulatory Framework for Dietary Supplements

In Japan, NMN products are currently classified as general foods or foods with functional claims (Kinou-sei Hyouji Shokuhin), not as pharmaceuticals or medical devices. This classification directly determines which regulatory framework governs their labeling requirements.

The primary applicable laws are:

• Food Sanitation Act (*Shokuhin Eiseihou*): Establishes safety standards for food production and distribution, and imposes a fundamental obligation to avoid misleading labeling.
• Health Promotion Act (*Kenkou Zousin Hou*): Prohibits exaggerated health claims for food products and restricts functional language on products that have not been designated as Foods for Specified Health Uses (FOSHU).
• Act against Unjustifiable Premiums and Misleading Representations (*Keihintouji Hou*): Regulates false or superiority-implying representations; unsubstantiated ingredient content claims fall under the scope of this law.
• Food Labeling Act (*Shokuhin Hyouji Hou*) and its implementing Food Labeling Standards (*Shokuhin Hyouji Kijun*): Establishes uniform requirements for all food label elements, including product name, ingredients, net quantity, expiration date, storage instructions, and manufacturer information.

The Foods with Functional Claims system, established in 2015, permits companies to make limited functional statements after filing a scientific evidence dossier with the Consumer Affairs Agency (CAA). However, the application of this system to NMN remains under strict scrutiny. The vast majority of NMN products on the market circulate as general foods and may not carry any functional claims on the principal display panel.

---

2. Ingredient Content Labeling Requirements: Core Disclosure Dimensions for NMN

2.1 Per-Serving and Daily Intake Disclosure Obligations

Japan's Food Labeling Standards require dietary supplements to clearly indicate on the label the ingredient content corresponding to each serving unit (e.g., one capsule, one sachet) and the recommended daily intake, enabling consumers to calculate their actual intake.

For NMN products, a compliant label must clearly present:

• The actual NMN content per unit (capsule/sachet/packet), expressed in milligrams (mg)
• The recommended daily serving (number of units or grams)
• The resulting calculated daily NMN intake

Common non-compliance patterns: Some products prominently promote "high-potency" or similar claims on the principal display panel, while the actual figures appear only in very small print on the back ingredient list — or NMN is deliberately obscured within a "proprietary blend," making it impossible to identify its individual content. The CAA has made clear in multiple guidance documents that such practices may constitute a "superiority-implying misrepresentation" under the Act against Unjustifiable Premiums and Misleading Representations.

2.2 Purity and Raw Material Traceability Disclosure

NMN raw materials are produced via two distinct manufacturing routes: fermentation and chemical synthesis. These processes differ in purity profiles and impurity spectra. While Japan does not mandate disclosure of the manufacturing method, higher-transparency companies voluntarily publish supplier credentials, third-party certificates of analysis (CoA), and batch testing data on product documentation or their corporate websites.

When evaluating a product, consumers may look for the following verifiable information:

• Whether the raw material supplier or country of origin is disclosed
• Whether a certificate of analysis from a recognized third-party testing body is available (e.g., Japan Food Research Laboratories, SGS, Eurofins)
• Whether NMN purity is explicitly stated (industry convention generally requires ≥98%)

2.3 Labeling Requirements for Additional Nutritional Ingredients

Where a product is formulated with other active ingredients — such as vitamins, minerals, or coenzyme Q10 — the Food Labeling Standards require individual content disclosure for all principal ingredients. "Multi-ingredient" or "complex formula" products that list only a total weight without breaking down each component's content are considered incompletely labeled.

---

3. Product Label Compliance Requirements

3.1 Prohibited Claims: Defining the Boundaries

This is the most critical compliance concern in NMN product labeling. Under Japan's Health Promotion Act and Act against Unjustifiable Premiums and Misleading Representations, NMN products marketed as general foods must not include any disease names, disease prevention or treatment claims, or claims of restoring the function of bodily organs or systems — on packaging, package inserts, advertising, or corporate websites.

Specifically, the following types of statements are non-compliant in labeling and promotional materials:

• Claims relating to the improvement, prevention, or adjuvant treatment of specific diseases
• Statements implying repair or regeneration of cells, DNA, or organs
• Functional language (beyond general "anti-aging" descriptions) that has not been filed under the Foods with Functional Claims system

Since 2021, the CAA has conducted multiple rounds of targeted inspections of the dietary supplement industry and has issued administrative guidance orders or demanded public corrective notices from companies that published non-compliant claims on social media and e-commerce platforms.

3.2 Mandatory Label Elements

Under the Food Labeling Act, NMN products sold within Japan must include at minimum the following elements:

For imported products placed on the market, a -language label is required, and the importer must appear on the label as the responsible party.

3.3 GMP Certification and Factory Credentials on Labels

The Japan Health and Nutrition Food Association (JHNFA, *Koueki Zaidan Houjin Nihon Kenkou Eiyo Shokuhin Kyoukai*) operates a voluntary GMP Conformity Certification program for dietary supplement manufacturers. Applicants are assessed across raw material management, in-process controls, finished product testing, and documentation practices; upon approval, a certification registration number is issued.

This certification is not a statutory requirement, but it is a widely recognized voluntary quality assurance standard within the industry. The certification registration numbers of JHNFA GMP-certified facilities are publicly verifiable through JHNFA's official certification database. For example, a facility holding certification number 34225 can be cross-referenced in the Association's published registry to confirm its certification status and validity period. When a product label bears such a certification claim, consumers should independently verify the registration number against the official database rather than relying solely on the label's representation.

---

4. Cross-Border Purchase Compliance

4.1 Japan to Mainland China: Personal Import and Mail/Courier Rules

Personal carriage upon entry: Under current Customs regulations, travelers bringing foreign health food products into China for personal use in reasonable quantities are generally subject to the postal and personal baggage tax regime. In practice, NMN products manufactured in Japan as dietary supplements may be classified by Customs as "health foods" or "foods," with the applicable duty rate and customs treatment varying accordingly. Quantities clearly exceeding what is reasonable for personal use may be subject to import duties or seizure.

Mail and courier shipments: The personal importation of unregistered foreign health food products through international mail or courier channels carries regulatory compliance risk. China's Administrative Measures for the Registration and Filing of Health Foods require that products imported under the health food designation obtain a registration approval number issued by the National Medical Products Administration (the "blue cap" certification). Commercial-scale importation without such registration is non-compliant.

The majority of NMN products currently on the market have not obtained health food registration approval. Cross-border e-commerce channels rely on the cross-border e-commerce retail import policy framework (personal import) rather than general trade import, and the two pathways differ substantially in their regulatory requirements. Consumers should take care to understand the compliance basis of the channel they are using.

4.2 Japan to Mainland China: Compliant Cross-Border E-Commerce Channels

Under the Cross-Border E-Commerce Retail Import policy, consumers purchasing foreign products through registered cross-border e-commerce platforms are covered by the personal import policy framework, subject to the following conditions:

• A single transaction must not exceed CNY 5,000, with an annual cumulative limit not exceeding CNY 26,000 (figures current as of publication; verify against the latest applicable regulations)
• Products must not contain ingredients explicitly prohibited from import into China
• Transactions must be processed through customs-registered cross-border e-commerce platforms and bonded warehouse logistics channels

Even when purchased through a compliant cross-border e-commerce channel, NMN products within China are regulated as food rather than health food. Any domestic promotional activity must comply with China's Advertising Law and applicable health food regulations.

4.3 Compliance Overview for Other Destination Markets

• United States: The FDA's position on NMN's status as a dietary supplement ingredient was under active discussion from 2022 through 2023, and its compliance classification remains subject to change. Consult the latest FDA guidance documents for current status.
• European Union: Regulatory requirements for dietary supplements vary across member states. Some EU countries impose higher pre-market compliance requirements for NMN than Japan does. Confirm the specific requirements of the target market before procurement.
• Hong Kong SAR: No pre-market registration is required for general health supplements in Hong Kong, but disease-related claims on labels or in advertising are equally prohibited.

---

5. Actionable Consumer Guidance

Based on the compliance framework described above, consumers purchasing NMN products through cross-border channels can conduct the following independent, verifiable evaluation:

• 1. Verify completeness of ingredient content labeling. Confirm that the label states the per-serving NMN content in milligrams and the total recommended daily intake as explicit figures, rather than relying solely on qualitative language such as "high-potency" or "ultra-pure formula."
• 2. Identify non-compliant efficacy claims. If a product's label, advertising, or sales description includes any disease name, treatment claim, or promise of specific physiological repair effects, treat this as a red flag. Such statements are non-compliant in Japan and also violate China's advertising regulations.
• 3. Verify factory credentials. If a product claims JHNFA GMP Conformity Certification, visit the JHNFA official website (jhnfa.org) and search the certified facility registry by registration number to confirm authenticity and current validity. Registration numbers are unique identifiers that allow for precise verification.
• 4. Review third-party testing reports. Prioritize brands that publicly disclose batch-level certificates of analysis (CoA), allowing you to verify that actual measured NMN content is consistent with the labeled amount, and that safety indicators such as heavy metals and microbiological contamination meet the reported standards.
• 5. Confirm channel compliance. When purchasing via cross-border e-commerce platforms, verify whether the platform holds Customs cross-border e-commerce registration. Avoid large-volume purchases through unofficial daigou (personal shopper) arrangements, which carry risks of customs seizure and limited recourse for quality issues.
• 6. Retain proof of purchase and product information. Keep records of your purchase, including the product batch number and production date, to facilitate complaint or traceability procedures in the event of a product issue.

---

Conclusion

Compliance in NMN product labeling is, at its core, a question of information transparency. Japan's regulatory framework — spanning the Food Labeling Act, the Act against Unjustifiable Premiums and Misleading Representations, and related legislation — requires companies to ground consumer decision-making in verifiable data rather than subjective efficacy claims. Accurate ingredient content disclosure, independently verifiable factory credentials, and publicly available third-party test data are the defining characteristics that distinguish high-transparency products from lower-quality alternatives.

For cross-border consumers, the fundamental path to minimizing quality and legal risk is understanding the regulatory differences between the source market and the destination market, selecting products with complete compliance disclosures, and purchasing through compliant channels. Regulatory policy is continuously evolving; consumers are advised to consult the latest guidance issued by the relevant market supervisory authorities before making purchasing decisions.

---

*This document is compiled from publicly available regulatory materials and industry standards. It does not constitute legal or medical advice. Dietary supplements are not a substitute for a balanced diet, are not pharmaceutical products, and are not intended to diagnose, treat, cure, or prevent any disease.*